Re-Growing Heart Tissue After Damage
Posted on: Thursday, 23 July 2009, 09:25 CDT
Heart tissue has been known to not have the ability to re-grow, but researchers at Children's Hospital Boston are working on ways to regenerate heart tissue after damage.
Researchers found after injecting animals with the growth factor neuregulin1 (NRG1) following a heart attack, heart regeneration increased and pumping function improved compared with controls. The animals were injected once daily for 12 weeks following a heart attack. Researchers were able to restart the cell cycle with NRG1, stimulating cardiomyocytes to divide and make copies of themselves even though they were not stem cells.
The mice who received NRG1 did not have the left-ventricular dilation and cardiac hypertrophy, which are usually encountered in heart failure. The researchers also stimulated production of a cellular receptor for NRG1, known as ErB4, and found that cardiomyocyte proliferation was further enhanced.
"NRG1 works when given by systemic injection -- a very promising result that suggests it may be feasible to use this in the clinic to treat heart failure," Bernhard Kuhn, M.D., a pediatric cardiologist at Children's Hospital Boston and the study's senior investigator, was quoted saying.
Experts hope the study results will lead to improved treatments for patients who suffer heart attacks or heart failure as well as children with congenital heart defects.
SOURCE: Cell, July 2009
Source: Ivanhoe
Related Articles
- Harrison City ROCKS! Set for August 15, Music Festival to Benefit Cardiac Research at Children's Hospital of Pittsburgh
- Researchers at Children's Healthcare of Atlanta and Emory University School of Medicine Make New Discovery in Pediatric Heart Disease Diagnosis
- Heart Tests Recommended for Children Before Taking ADHD Drugs
- Pfizer Discontinues Heart Disease Research
- The Children's Heart Center at Phoenix Children's Opens the Only Pediatric Cath Lab in Arizona and the Only Hybrid Catheterization Lab in the Southwest
- GE Healthcare Installs First Volume CT System Dedicated Exclusively for Pediatric Applications; LightSpeed VCT to Be Used in Clinical Research on Children With Heart Defects
- Steroids reduce heart damage risk in children with Kawasaki's disease
- I'Ve Survived a Heart Transplant, Kidney Failure & Pneumonia ..Now I'Ll Beat Cancer
- Heart-Disease Research Focuses on Drug for African-Americans Shands Jacksonville Was Part of a Clinical Trial of BiDil, Which is Being Marketed for One Race.
- Pittsburgh Researchers Study Children's Respiratory Problems Caused By Virus
User Comments (1)
| 1. |
Posted by cpunt2002@gmail.com on 11/12/2009, 04:19 how is it possible to contact someone to do with this technology? cpunt2002@gmail.com 604-5333777 |

RSS Feeds